Treatment of Wilson's disease with zinc. XVII: Treatment during pregnancy

Hepatology

Volumn 31, Issue 2, 2000, Pages 364-370

  Brewer, George J ^a   Johnson, Virginia D ^a   Dick, Robert D ^a   Hedera, Peter ^a   Fink, John K ^a   Kujin, Karen J ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; PENICILLAMINE; TRIENTINE; ZINC;

ADULT; ARTICLE; CHILDBIRTH; CLINICAL ARTICLE; COPPER BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LIVER FUNCTION TEST; MATERNAL WELFARE; NEUROLOGIC EXAMINATION; PREGNANCY DISORDER; PRIORITY JOURNAL; TERATOGENICITY; URINE LEVEL; WILSON DISEASE;

EID: 0033950355     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.510310216     Document Type: Article

References (17)

1. Brewer GJ, Yuzbasiyan-Gurkan V. Wilson disease. Medicine 1992;71:139-164.
2. Bull PC, Thomas GR, Rommens JM, Forbes JR, Cox DW. The Wilson disease gene is a putative copper transporting P-type ATPase similar to the Menkes gene. Nat Genet 1993;5:327-337.
3. Tanzi RE, Petrukhin K, Chernov I, Pellequer JL, Wasco W, Ross B, Parano E, et al. The Wilson disease gene is a copper transporting ATPase with homology to the Menkes disease gene. Nat Genet 1993;5:44-50.
4. Yamaguchi Y, Heiny ME, Gitlin JD. Isolation and characterization of a human liver cDNA as a candidate gene for Wilson disease. Biochem Biophy Res Commun 1993;197:271-277.
5. Bush JA, Mahoney JP, Markowitz H, Gubler CJ, Cartwright GE, Wintrobe MM. Studies on copper metabolism. XVI. Radioactive copper studies in normal subjects and in patients with hepatolenticular degeneration. J Clin Invest 1955;34:1766-1778.
6. Frommer DJ. Defective biliary excretion of copper in Wilson's disease. Gut 1974;15:125-129.
7. O'Reilly S, Weber PM, Oswald M, Shipley L. Abnormalities of the physiology of copper in Wilson's disease. III. The excretion of copper. Arch Neurol 1971;25:28-32.
8. Gibbs K, Walshe JM. Biliary excretion of copper in Wilson's disease. Lancet 1980;2:538-539.
9. Iyengaar V, Brewer GJ, Dick RD, Owyang, C. Studies of cholecystokinin-stimulated biliary secretions reveal a high molecular weight copper-binding substance in normal subjects that is absent in patients with Wilson's disease. J Lab Clin Med 1988;111:267-274.
10. Walshe, JM. Penicillamine. A new oral therapy for Wilson's disease. Am J Med 1956;21:487-495.
11. Walshe JM. Treatment of Wilson's disease with trientine (triethylene tetramine) dihydrochloride. Lancet 1982;1:643-647.
12. Brewer GJ, Hill GM, Prasad AS, Cossack ZT, Rabbani P. Oral zinc therapy for Wilson's disease. Ann Intern Med 1983;99:314-320.
13. Hill GM, Brewer GJ, Prasad AS, Hydrick CR, Hartmann DE. Treatment of Wilson's disease with zinc: I. Oral zinc therapy regimens. HEPATOLOGY 1987;7:522-528.
14. 64 copper uptake with copper balance. Am J Med Sci 1986;12:344-349.
15. Brewer GJ, Hill GM, Dick RD, Nostrant TT, Sams JS, Wells JJ, Prasad AS. Treatment of Wilson's disease with zinc: III. Prevention of reaccumulation of hepatic copper. J Lab Clin Med 1987;109:526-531.
16. Brewer GJ, Hill GM, Prasad AS, Dick RD. Treatment of Wilson's disease with zinc: IV. Efficacy monitoring using urine and plasma copper. Proc Soc Exper Biol Med 1987;7:446-455.
17. Yuzbasiyan-Gurkan V, Brewer GJ, Abrams GD, Main B, Giacherio D. Treatment of Wilson's disease with zinc: V Changes in serum levels of lipase, amylase and alkaline phosphatase in Wilson's disease patients. J Lab Clin Med 1989;114:520-526.